Budget Impact and Investment Case for HEARTS Hypertension Control Programs in 4 Low- and Middle-Income Countries
Authors' conclusion
Scale-up of HEARTS HTN control package may provide increased health gains and economic benefits over time.
Study context
- Population
- 4 low- and middle-income countries with HEARTS programs: Bangladesh, Ethiopia, Nigeria, and the Philippines
- Comparison
- Increasing HEARTS hypertension (HTN) treatment coverage by 15 percentage points from 2025 to 2040
- Outcome
- Cost of scaling up HEARTS treatment coverage
- Follow-up
- By 2040
Methodological detailsBase and alternative cost scenarios
- Base and alternative cost scenarios
Main finding
As reported in the abstract
Bangladesh
$2.9 billion
Nigeria
$1.7 billion
The Philippines
$0.9 billion
Ethiopia
$0.5 billion
Further findings
| Outcome | Bangladesh | Nigeria | Ethiopia | The Philippines |
|---|---|---|---|---|
| Deaths prevented · by 2040 | 120,000 | 77,500 | 47,200 | 82,000 |
- Deaths prevented — HEARTS scale-up can prevent more than 300,000 deaths by 2040
- 300,000
Cost per primary care user and per patient treated
- Cost per primary care user
- $3 to 16
- Cost per patient treated
- $27 to 67
- Across the 4 countries
Alternative scenarios assuming lower-cost components
- Identified ways to improve HEARTS affordability and economic returns
Original publication
Budget Impact and Investment Case for HEARTS Hypertension Control Programs in 4 Low- and Middle-Income Countries. JACC Adv. Published 9 December 2025. doi:10.
Summarised from the published abstract; every number is checked against it